Literature DB >> 8466646

Induction of O6-methylguanine-DNA-methyltransferase and N3-methyladenine-DNA-glycosylase in human cells exposed to DNA-damaging agents.

P Lefebvre1, P Zak, F Laval.   

Abstract

The inducibility of two DNA repair proteins, the O6-methylguanine-DNA-methyltransferase (MGMT) and the N3-methyladenine-DNA-glycosylase (ANPG), was studied by measuring the protein activities and the transcription of the MGMT and ANPG genes in a human hepatoma cell line (LICH cells). The two protein activities are enhanced after treatment with a variety of DNA-damaging agents. They are maximum 72 hr after the inducing treatments and remain elevated for about 120 hr. This induction is abolished when the cells are grown in the presence of protein or RNA synthesis inhibitors. Northern blot analysis shows that the DNA-damaging agents increase to different extents the transcription of the MGMT or ANPG genes. The transferase activity is also increased by DNA damage in a human glioblastoma cell line (T98G cells), but is not significantly modified in human normal fibroblasts, suggesting that this repair activity enhancement might occur preferentially in transformed cells, as we have previously shown for cells of rat origin. Therefore, these increased repair activities may play an important role in removing the lethal N3-methyladenine residues, the promutagenic O6-methylguanine lesions, and the potentially lethal chloroethyl adducts formed by the nitrosoureas used in cancer chemotherapy more efficiently from the cellular DNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466646     DOI: 10.1089/dna.1993.12.233

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  5 in total

1.  Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.

Authors:  Gaspar J Kitange; Brett L Carlson; Mark A Schroeder; Patrick T Grogan; Jeff D Lamont; Paul A Decker; Wenting Wu; C David James; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2008-10-24       Impact factor: 12.300

2.  Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I.

Authors:  M J Prieto-Alamo; F Laval
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  Purification and characterization of human 3-methyladenine-DNA glycosylase.

Authors:  T R O'Connor
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

4.  Molecular cloning and functional analysis of a human cDNA encoding an Escherichia coli AlkB homolog, a protein involved in DNA alkylation damage repair.

Authors:  Y F Wei; K C Carter; R P Wang; B K Shell
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

5.  A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.

Authors:  Rheal A Towner; Michael Ihnat; Debra Saunders; Anja Bastian; Nataliya Smith; Roheeth Kumar Pavana; Aleem Gangjee
Journal:  BMC Cancer       Date:  2015-07-17       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.